Cargando…
氟达拉滨和环磷酰胺联合利妥昔单抗(FCR方案)一线治疗慢性淋巴细胞白血病43例临床分析
OBJECTIVE: To investigate the efficacy of fludarabine and cyclophosphamide combined with rituximab(FCR)in previously untreated patients with chronic lymphocytic leukemia(CLL). METHODS: The clinical data of 43 enrolled patients from May 2004 to December 2017 were analyzed the efficacy and survival re...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408492/ https://www.ncbi.nlm.nih.gov/pubmed/34455740 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.07.003 |
Ejemplares similares
-
地塞米松、利妥昔单抗联合环磷酰胺治疗18例华氏巨球蛋白血症临床分析
Publicado: (2018) -
沙利度胺联合环磷酰胺和地塞米松治疗症状性华氏巨球蛋白血症的前瞻性临床研究
Publicado: (2023) -
硼替佐米、利妥昔单抗、环磷酰胺、阿霉素和泼尼松(VR-CAP)方案治疗初治套细胞淋巴瘤60例的疗效及预后分析
Publicado: (2021) -
长春瑞滨联合异环磷酰胺三线以后治疗晚期非小细胞肺癌的疗效和不良反应
Publicado: (2015) -
BTK抑制剂联合苯达莫司汀、利妥昔单抗一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的疗效及安全性
Publicado: (2023)